HISTOGEN INC.
Profile
Company Names
HISTOGEN INC.
CONATUS PHARMACEUTICALS INC
Addresses
10655 SORRENTO VALLEY ROAD, SUITE 200, SAN DIEGO, CA 92121
4365 EXECUTIVE DIRVE, SUITE 200, SAN DIEGO, CA 92121
4365 EXECUTIVE DRIVE, SUITE 200, SAN DIEGO, CA 92121
Phone Numbers
(858) 526-3100
(858) 457-7221
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$36,466,266.00
Number of Funding Rounds:
5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-07-14
$5,000,000.00
$5,000,000.00
$0.00
4
2020-11-16
$189,208.00
$189,208.00
$0.00
3
2013-05-30
$1,001,551.00
$1,001,551.00
$0.00
Debt
2
2011-02-09
$25,275,507.00
$25,275,507.00
$0.00
Equity
1
2010-03-05
$5,000,000.00
$5,000,000.00
$0.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
WILLIAM
GERBER
DIRECTOR
WILLIAM
GERBER, M.D.
DIRECTOR
DAVID
F.
HALE
DIRECTOR
SKINMEDICA INC
| SOMAXON PHARMACEUTICALS, INC.
| NEURELIS, INC.
| RIDGE DIAGNOSTICS, INC.
| CONATUS PHARMACEUTICALS INC
| AGILITY CLINICAL, INC.
| COLORESCIENCE INC
| TOKALAS, INC.
| RECROS MEDICA, INC.
| IDUN PHARMACEUTICALS INC
| MDREJUVENA, INC.
| DERMATA THERAPEUTICS, LLC
| ONCTERNAL THERAPEUTICS, INC.
| ADIGICA HEALTH, INC.
| NEURANA PHARMACEUTICALS, INC.
| CLARIFY MEDICAL, INC.
| ONCTERNAL THERAPEUTICS, INC.
JONATHAN
JACKSON
DIRECTOR
PAUL
KLINGENSTEIN
DIRECTOR
LOUIS
LACASSE
DIRECTOR
SHAHZAD
MALIK
DIRECTOR
CONATUS PHARMACEUTICALS INC
| PATHWORK DIAGNOSTICS INC
| VERSARTIS, INC.
| ACUTUS MEDICAL, INC.
| IDUN PHARMACEUTICALS INC
| ADVENT LIFE SCIENCES FUND II LP
| AGENUS INC
| NALU MEDICAL, INC.
| AXONICS MODULATION TECHNOLOGIES, INC.
| ITERUM THERAPEUTICS LTD
| ADVENT LIFE SCIENCES FUND III LP
| ITERUM THERAPEUTICS BERMUDA LTD
| ITERUM THERAPEUTICS PLC
| ITERUM THERAPEUTICS US LTD
| ITERUM THERAPEUTICS US HOLDING LTD
| ITERUM THERAPEUTICS INTERNATIONAL LTD
| ADVENT-HARRINGTON IMPACT FUND LP
| MOXIMED, INC
| ADVENT LIFE SCIENCES GROWTH FUND LP
STEVEN
J.
MENTO
EXECUTIVE OFFICER, DIRECTOR
STEVEN
J.
MENTO, PH.D.
EXECUTIVE OFFICER, DIRECTOR
GAIL
NAUGHTON
EXECUTIVE OFFICER
RICHARD
W.
PASCOE
EXECUTIVE OFFICER, DIRECTOR
JAMES
SCOPA
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2013-05-30

